IB-Stim is the first FDA-indicated treatment for pediatric IBS, providing a non-invasive option that helps improve patient quality of life. What is the significance of the CPT Category I code for ...

Irritable bowel syndrome is the most common cause of chronic diarrhea and lower abdominal discomfort in North America.

Emma King's sister Hayley is now speaking out in a bid to stop others being diagnosed late so that, unlike her sister who ...

NeurAxis's robust sales growth and disciplined cost management have set the stage for achieving cash flow breakeven in 2026. Notably, recent investments from life science-focused funds have bolstered ...

Functional abdominal pain (FAP) and irritable bowel syndrome (IBS) are among the most commonly diagnosed medical problems in pediatrics. Symptom-based Rome III criteria for FAP and IBS have been ...

A FIT and healthy mum was told by doctors her persistent tummy problems were caused by a food intolerance and irritable bowel syndrome. But two years later, Emma King’s symptoms became ...

A mum who was reportedly told by doctors that her stomach issues were caused by irritable bowel syndrome (IBS) has died of ...

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...

2024 marked a groundbreaking year for IB-Stim, the first FDA-indicated treatment specifically designed for Pediatric IBS. Powered by our innovative and patented PENFS technology, IB-Stim was ...

Medically reviewed by Qin Rao, MD Irritable bowel syndrome (IBS) is a common digestive disorder that affects the large ...